Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M306580200 on August 7, 2003

J. Biol. Chem., Vol. 278, Issue 42, 40859-40866, October 17, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/42/40859    most recent
M306580200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paromov, V. M.
Right arrow Articles by Morton, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paromov, V. M.
Right arrow Articles by Morton, R. E.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Lipid Transfer Inhibitor Protein Defines the Participation of High Density Lipoprotein Subfractions in Lipid Transfer Reactions Mediated by Cholesterol Ester Transfer Protein (CETP)*

Viktor M. Paromov and Richard E. Morton {ddagger}

From the Department of Cell Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195

Cholesterol ester transfer protein (CETP) moves triglyceride (TG) and cholesteryl ester (CE) between lipoproteins. CETP has no apparent preference for high (HDL) or low (LDL) density lipoprotein as lipid donor to very low density lipoprotein (VLDL), and the preference for HDL observed in plasma is due to suppression of LDL transfers by lipid transfer inhibitor protein (LTIP). Given the heterogeneity of HDL, and a demonstrated ability of HDL subfractions to bind LTIP, we examined whether LTIP might also control CETP-facilitated lipid flux among HDL subfractions. CETP-mediated CE transfers from [3H]CE VLDL to various lipoproteins, combined on an equal phospholipid basis, ranged 2-fold and followed the order: HDL3 > LDL > HDL2. LTIP inhibited VLDL to HDL2 transfer at one-half the rate of VLDL to LDL. In contrast, VLDL to HDL3 transfer was stimulated, resulting in a CETP preference for HDL3 that was 3-fold greater than that for LDL or HDL2. Long-term mass transfer experiments confirmed these findings and further established that the previously observed stimulation of CETP activity on HDL by LTIP is due solely to its stimulation of transfer activity on HDL3. TG enrichment of HDL2, which occurs during the HDL cycle, inhibited CETP activity by ~2-fold and LTIP activity was blocked almost completely. This suggests that LTIP keeps lipid transfer activity on HDL2 low and constant regardless of its TG enrichment status. Overall, these results show that LTIP tailors CETP-mediated remodeling of HDL3 and HDL2 particles in subclass-specific ways, strongly implicating LTIP as a regulator of HDL metabolism.

Received for publication, June 20, 2003 , and in revised form, July 28, 2003.

* This research was supported in part by Grant HL60934 from the NHLBI, National Institutes of Health and Grant 0050075N from the American Heart Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed: Dept. of Cell Biology, NC 10, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195. Tel.: 216-444-5850; Fax: 216-444-9404; E-mail: mortonr{at}ccf.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
D. L. Rainwater, L. A. Cox, J. Rogers, J. L. VandeBerg, and M. C. Mahaney
Localization of multiple pleiotropic genes for lipoprotein metabolism in baboons
J. Lipid Res., July 1, 2009; 50(7): 1420 - 1428.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
L. Izem and R. E. Morton
Molecular cloning of hamster lipid transfer inhibitor protein (apolipoprotein F) and regulation of its expression by hyperlipidemia
J. Lipid Res., April 1, 2009; 50(4): 676 - 684.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. S. Green, T. Vaisar, S. Pennathur, J. J. Kulstad, A. B. Moore, S. Marcovina, J. Brunzell, R. H. Knopp, X.-Q. Zhao, and J. W. Heinecke
Combined Statin and Niacin Therapy Remodels the High-Density Lipoprotein Proteome
Circulation, September 16, 2008; 118(12): 1259 - 1267.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
Y. He, D. J. Greene, M. Kinter, and R. E. Morton
Control of cholesteryl ester transfer protein activity by sequestration of lipid transfer inhibitor protein in an inactive complex
J. Lipid Res., July 1, 2008; 49(7): 1529 - 1537.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
R. E. Morton, H. M. Gnizak, D. J. Greene, K.-H. Cho, and V. M. Paromov
Lipid transfer inhibitor protein (apolipoprotein F) concentration in normolipidemic and hyperlipidemic subjects
J. Lipid Res., January 1, 2008; 49(1): 127 - 135.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
T. Y Li, C. Zhang, F. W Asselbergs, L. Qi, E. Rimm, D. J Hunter, and F. B Hu
Interaction between dietary fat intake and the cholesterol ester transfer protein TaqIB polymorphism in relation to HDL-cholesterol concentrations among US diabetic men
Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1524 - 1529.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
N. Barzilai, G. Atzmon, C. A. Derby, J. M. Bauman, and R. B. Lipton
A genotype of exceptional longevity is associated with preservation of cognitive function
Neurology, December 26, 2006; 67(12): 2170 - 2175.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. P. Conway and M. Kinter
Dual Role of Peroxiredoxin I in Macrophage-derived Foam Cells
J. Biol. Chem., September 22, 2006; 281(38): 27991 - 28001.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
J. P. Conway and M. Kinter
Proteomic and Transcriptomic Analyses of Macrophages with an Increased Resistance to Oxidized Low Density Lipoprotein (oxLDL)-induced Cytotoxicity Generated by Chronic Exposure to oxLDL
Mol. Cell. Proteomics, October 1, 2005; 4(10): 1522 - 1540.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
G. F. Lewis and D. J. Rader
New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport
Circ. Res., June 24, 2005; 96(12): 1221 - 1232.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
R. E. Morton and D. J. Greene
CETP and lipid transfer inhibitor protein are uniquely affected by the negative charge density of the lipid and protein domains of LDL
J. Lipid Res., December 1, 2003; 44(12): 2287 - 2296.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement